UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 478

Sortiert nach

Alemtuzumab in the long-term treatment of relapsing-remitting multiple sclerosis: an update on the clinical trial evidence and data from the real world

Therapeutic advances in neurological disorders, 2017-10, Vol.10 (10), p.343-359

2017

Volltextzugriff (PDF)

The Investigation of the Cardiovascular and Sudomotor Autonomic Nervous System-A Review

Frontiers in neurology, 2019-02, Vol.10, p.53-53

2019

Volltextzugriff (PDF)

A focus on secondary progressive multiple sclerosis (SPMS): challenges in diagnosis and definition

Journal of neurology, 2021-04, Vol.268 (4), p.1210-1221

2021

Volltextzugriff (PDF)

Peripheral proinflammatory Th1/Th17 immune cell shift is linked to disease severity in amyotrophic lateral sclerosis

Scientific reports, 2020-04, Vol.10 (1), p.5941-5941, Article 5941

2020

Volltextzugriff (PDF)

Demands on response inhibition processes determine modulations of theta band activity in superior frontal areas and correlations with pupillometry – Implications for the norepinephrine system during inhibitory control

NeuroImage (Orlando, Fla.), 2017-08, Vol.157, p.575-585

2017

Volltextzugriff (PDF)

Digital Twins for Multiple Sclerosis

Frontiers in immunology, 2021-05, Vol.12, p.669811-669811

2021

Volltextzugriff (PDF)

How to reduce the delay of diagnosing secondary progression in multiple sclerosis

Multiple sclerosis, 2021-04, Vol.27 (4), p.646-647

2021

Volltextzugriff (PDF)

Natalizumab during pregnancy and lactation

Multiple sclerosis, 2018-10, Vol.24 (12), p.1627-1634

2018

Volltextzugriff (PDF)

Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial

Lancet neurology, 2017-03, Vol.16 (3), p.189-199

2017

Volltextzugriff (PDF)

Assessing the immune response to SARS-CoV-2 mRNA vaccines in siponimod-treated patients: a nonrandomized controlled clinical trial (AMA-VACC)

Therapeutic advances in neurological disorders, 2022-01, Vol.15, p.175628642211353-17562864221135305

2022

Volltextzugriff (PDF)

Psychoneuroimmunology - psyche and autoimmunity

Current pharmaceutical design, 2012-10, Vol.18 (29), p.4485

Ziemssen, Tjalf

2012

Volltextzugriff (PDF)

The need for a strategic therapeutic approach: multiple sclerosis in check

Therapeutic Advances in Chronic Disease, 2022-01, Vol.13, p.20406223211063032-20406223211063032

2022

Volltextzugriff (PDF)

Differentiating societal costs of disability worsening in multiple sclerosis

Journal of neurology, 2020-04, Vol.267 (4), p.1035-1042

2020

Volltextzugriff (PDF)

Neutralizing antibody titers over 12 months after SARS-CoV-2 mRNA vaccine booster in patients with relapsing multiple sclerosis continuously treated with ofatumumab

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2316422-2316422

2024

Volltextzugriff (PDF)

Therapy satisfaction and adherence in patients with relapsing–remitting multiple sclerosis: the THEPA-MS survey

Therapeutic advances in neurological disorders, 2016-07, Vol.9 (4), p.250-263

2016

Volltextzugriff (PDF)

Acute Effects of Ocrelizumab Infusion in Multiple Sclerosis Patients

International journal of molecular sciences, 2022-11, Vol.23 (22), p.13759

2022

Volltextzugriff (PDF)

Approach to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis

Frontiers in immunology, 2021-06, Vol.12, p.701752-701752

2021

Volltextzugriff (PDF)

Building digital patient pathways for the management and treatment of multiple sclerosis

Frontiers in immunology, 2024, Vol.15, p.1356436-1356436

2024

Volltextzugriff (PDF)

S1P receptor modulators and the cardiovascular autonomic nervous system in multiple sclerosis: a narrative review

Therapeutic Advances in Neurological Disorders, 2022-01, Vol.15, p.175628642211331-17562864221133163

2022

Volltextzugriff (PDF)

Data Collection in Multiple Sclerosis: The MSDS Approach

Frontiers in neurology, 2020-06, Vol.11, p.445-445

2020

Volltextzugriff (PDF)

Interleukin-17 and Th17 Lymphocytes Directly Impair Motoneuron Survival of Wildtype and FUS-ALS Mutant Human iPSCs

International journal of molecular sciences, 2021-08, Vol.22 (15), p.8042

2021

Volltextzugriff (PDF)

Why Cognitive–Cognitive Dual-Task Testing Assessment Should Be Implemented in Studies on Multiple Sclerosis and in Regular Clinical Practice

Frontiers in neurology, 2020-08, Vol.11, p.905-905

2020

Volltextzugriff (PDF)

Case report: Variant-specific pre-exposure prophylaxis of SARS-CoV-2 infection in multiple sclerosis patients lacking vaccination responses

Frontiers in immunology, 2022-07, Vol.13

2022

Volltextzugriff (PDF)

Serum neurofilament indicates that DBS surgery can cause neuronal damage whereas stimulation itself does not

Scientific reports, 2022-01, Vol.12 (1), p.1446-1446, Article 1446

2022

Volltextzugriff (PDF)

Ella versus Simoa Serum Neurofilament Assessment to Monitor Treatment Response in Highly Active Multiple Sclerosis Patients

International journal of molecular sciences, 2022-10, Vol.23 (20), p.12361

2022

Volltextzugriff (PDF)

1 – 25 von 478

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

PublikationsformBerichte

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(406)
Mit Volltextzugriff
(426)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(353)
Life Sciences & Biomedicine
(341)
Multiple Sclerosis
(226)
Neurosciences & Neurology
(212)
Humans
(185)
Clinical Neurology
(172)
Neurosciences
(131)
Male
(96)
Female
(94)
Neurology
(92)
Patients
(77)
Adult
(75)
Middle Aged
(60)
Medicine
(49)
Medicine & Public Health
(43)
Young Adult
(35)
Multiple Sclerosis, Relapsing-Remitting - Drug Therapy
(33)
Aged
(32)
Immunology
(32)
Clinical Trials
(31)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Alemtuzumab in the long-term treatment of relapsing-remitting multiple sclerosis: an update on the clinical trial evidence and data from the real world

The Investigation of the Cardiovascular and Sudomotor Autonomic Nervous System-A Review

A focus on secondary progressive multiple sclerosis (SPMS): challenges in diagnosis and definition

Peripheral proinflammatory Th1/Th17 immune cell shift is linked to disease severity in amyotrophic lateral sclerosis

Demands on response inhibition processes determine modulations of theta band activity in superior frontal areas and correlations with pupillometry – Implications for the norepinephrine system during inhibitory control

Digital Twins for Multiple Sclerosis

How to reduce the delay of diagnosing secondary progression in multiple sclerosis

Natalizumab during pregnancy and lactation

Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial

Assessing the immune response to SARS-CoV-2 mRNA vaccines in siponimod-treated patients: a nonrandomized controlled clinical trial (AMA-VACC)

Psychoneuroimmunology - psyche and autoimmunity

The need for a strategic therapeutic approach: multiple sclerosis in check

Differentiating societal costs of disability worsening in multiple sclerosis

Neutralizing antibody titers over 12 months after SARS-CoV-2 mRNA vaccine booster in patients with relapsing multiple sclerosis continuously treated with ofatumumab

Therapy satisfaction and adherence in patients with relapsing–remitting multiple sclerosis: the THEPA-MS survey

Acute Effects of Ocrelizumab Infusion in Multiple Sclerosis Patients

Approach to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis

Building digital patient pathways for the management and treatment of multiple sclerosis

S1P receptor modulators and the cardiovascular autonomic nervous system in multiple sclerosis: a narrative review

Data Collection in Multiple Sclerosis: The MSDS Approach

Interleukin-17 and Th17 Lymphocytes Directly Impair Motoneuron Survival of Wildtype and FUS-ALS Mutant Human iPSCs

Why Cognitive–Cognitive Dual-Task Testing Assessment Should Be Implemented in Studies on Multiple Sclerosis and in Regular Clinical Practice

Case report: Variant-specific pre-exposure prophylaxis of SARS-CoV-2 infection in multiple sclerosis patients lacking vaccination responses

Serum neurofilament indicates that DBS surgery can cause neuronal damage whereas stimulation itself does not

Ella versus Simoa Serum Neurofilament Assessment to Monitor Treatment Response in Highly Active Multiple Sclerosis Patients

Aktive Filter

Suchergebnisse filtern